A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) - Related Studies

A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)

This study is ongoing, but not recruiting participants.

Study NCT00076401. Last updated on June 23, 2005. Information provided by Pharmacyclics

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Leukemia
		Leukemia, Lymphocytic, Chronic

2	Additional conditions recognized in this trial
		Leukemia, B-Cell
		Leukemia, Lymphocytic, Chronic, B-Cell
		Leukemia, Lymphoid

3	More general conditions related to this trial
		Immune System Diseases
		Immunoproliferative Disorders
		Lymphatic Diseases
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type

4	Interventions listed in this trial
		Motexafin gadolinium

5	More general drug interventions related to this trial
		Antineoplastic Agents
		Dermatologic Agents
		Pharmacologic Actions
		Photosensitizing Agents
		Physiological Effects of Drugs
		Radiation-Sensitizing Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		Pharmacyclics